The Current Ratio as of November 2025 (TTM) for Reneo Pharmaceuticals, Inc. (RPHM) is 11.13

According to Reneo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.13. This represents a change of -21.54% compared to the average of 14.19 of the last 4 quarters.

Reneo Pharmaceuticals, Inc. (RPHM) Historical Current Ratio (quarterly & annually)

How has RPHM Current Ratio performed in the past?

The mean historical Current Ratio of Reneo Pharmaceuticals, Inc. over the last ten years is 12.83. The current 11.13 Current Ratio has changed 8.58% with respect to the historical average. Over the past ten years (40 quarters), RPHM's Current Ratio was at its highest in in the June 2024 quarter at 57.86. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Reneo Pharmaceuticals, Inc. (RPHM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Reneo Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reneo Pharmaceuticals, Inc. (RPHM) Average Current Ratio

How has RPHM Current Ratio performed in the past?

The current Current Ratio of Reneo Pharmaceuticals, Inc. (RPHM) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Reneo Pharmaceuticals, Inc. (RPHM) Current Ratio vs. Peers

How is RPHM’s Current Ratio compared to its peers?

Reneo Pharmaceuticals, Inc.’s Current Ratio is greater than Achilles Therapeutics plc (6.04), greater than Heat Biologics, Inc. (0.09), greater than TCR2 Therapeutics Inc. (2.77), greater than Surface Oncology, Inc. (7.94), greater than Sigilon Therapeutics, Inc. (2.40), less than Kronos Bio, Inc. (12.93), greater than Quince Therapeutics, Inc. (5.00), greater than The Valens Company Inc. (1.97), less than AlloVir, Inc. (12.89), greater than Rein Therapeutics Inc. (0.90),

Build a custom stock screener for Reneo Pharmaceuticals, Inc. (RPHM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reneo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reneo Pharmaceuticals, Inc. (RPHM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reneo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.